As part of the Storm Chaser study, researchers at University College London Hospitals NHS Trust (UCLH) are exploring the use of an antibody that has the potential to provide long-term protection

A new antibody treatment, which could give people immediate protection after exposure to the coronavirus, is being tested in the UK

The antibody, known as AZD7442, was developed by the pharmaceutical company AstraZeneca 

The study entered phase three of the trials on December 2, with the aim of testing the new treatment on 1,125 people worldwide.

The trial's main groups include health workers, students living in shared accommodation, and patients who have recently been exposed to anyone with coronavirus, as well as those in long-term treatment, military, and industrial workers such as factory workers.